Treatment of inflammation with p20

Details Treatment of inflammation with p20 Treatment of inflammation with p20

2006-07-11

2006-07-11

Whiteman, Brian (Department: 1635)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C435S320100

Reexamination Certificate

active

07074399

ABSTRACT:
The present invention provides compositions, methods, and kits for treating inflammation and regulating inflammatory responses including cytokine, prostanoid, prostaglandin, and growth factor expression.

REFERENCES:
patent: 4937190 (1990-06-01), Palmenberg et al.
patent: 5215892 (1993-06-01), Kishimoto et al.
patent: 5360894 (1994-11-01), Kishimoto et al.
patent: 5545563 (1996-08-01), Darlington et al.
patent: 5804445 (1998-09-01), Brasier
patent: 5830725 (1998-11-01), Nolan et al.
patent: 5874209 (1999-02-01), Karin et al.
patent: 6165720 (2000-12-01), Felgner et al.
J Kuby, Immunology, WH Freeman and Company,2ndEd., pp. 7-9,313-316,318 and 559-560.
GM Rubanyi, Molecular Aspects of Medicine, “The future of human gene therapy,” 2001, 22, pp. 113-142.
WF Anderson, Nature, “Human gene therapy,” Apr. 1998, vol. 392, pp. 25-30.
IM Verma et al., Nature, “Gene therapy-promises, problems and prospects,” Sep. 1997, vol. 389, pp. 239-242.
Akira et al. EMBO J. 1990, 9:1897-1906.
Chang et al. Mol Cell Biol. 1990, 10:6642-53).
Poli et al. Cell, 63, 643-653, 1990.
Croniger, et al.;C/EBP and the Control of Phosphoenolpyruvate; Journal of Biological Chemistry; Nov. 28, 1998; pp. 31629-31632; vol. 273:48; USA.
Darlington, et al.;The Role of C/EBP Genes in Adipocyte Differentiation; Journal of Biological Chemistry; Nov. 13, 1998; pp. 30057-30060; vol. 273:46; USA.
Diehl;Roles of CCAAT/Enhancer-binding Proteins in Regulation of Liver Regenerative Growth; Journal of Biological Chemistry; Nov. 20, 1998; pp. 30843-30846; vol. 273:46; USA.
Hanson;Biological Role of the Isoforms of C/EBP Minireview Series; Journal of Biological Chemistry; Oct. 30, 1998; p. 28543; vol. 273:44; USA.
Harris, et al.;C/EBP Cooperates with p21 to inhibit cdk2 kinase activity and induces growth arrest independent of DNA binding; JBC Papers in Press; May 21, 2001; pp. 1-41.
Henderson, et al.;C/EBP Proteins Activate Transcription from the Human Immunodeficiency Virus Type I Long Terminal Repeat in Macrophages/Monocytes; Journal of Virology; Sep. 1995; pp. 5337-5344; vol. 69:9.
Honda, et al.;Type I Interferon Induces Inhibitory 16-kD CCAAT/Enhancer Binding Protein(C/EBP)β, Repressing the HIV-I Long Terminal Repeat in Macrophages: Pulmonary Tuberculosis Alters C/EBP Expression, Enhancing HIV-I Replication; J. Exp. Med.; Oct. 5, 1998; pp. 1255-1265; vol. 188:7.
Kowenz-Leutz, et al.;A C/EBPβ Isoform Recruits the SWI/SNF Complex to Activate Myeloid Genes; Molecular Cell; Nov. 1999; pp. 735-743; vol. 4.
Lekstrom-Himes, et. al.;Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors; Journal of Biological Chemistry; Oct. 30, 1998; pp. 28545-28548; vol. 273:44; USA.
Poli, Valeria;The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions; Journal of Biological Chemistry; Nov. 6, 1998; pp. 29279-29282; vol. 273:45; USA.

Affiliated with

Also associated with

Rating

Treatment of inflammation with p20 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of inflammation with p20, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammation with p20 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3558504